Sabra Healthcare REIT (NASDAQ:SBRA) Announces Earnings Results, Misses Expectations By $0.26 EPS

Sabra Healthcare REIT (NASDAQ:SBRA) issued its quarterly earnings data on Thursday. The real estate investment trust reported $0.11 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.37 by ($0.26), FiscalAI reports. The business had revenue of $201.35 million during the quarter, compared to the consensus estimate of $201.97 million. Sabra Healthcare REIT had a net margin of 23.50% and a return on equity of 6.38%. The company’s revenue for the quarter was up 16.2% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.36 EPS. Sabra Healthcare REIT updated its FY 2026 guidance to 1.550-1.590 EPS.

Sabra Healthcare REIT Stock Up 3.3%

Shares of NASDAQ SBRA opened at $20.25 on Friday. Sabra Healthcare REIT has a 1 year low of $15.60 and a 1 year high of $20.27. The firm’s 50-day moving average is $19.02 and its 200-day moving average is $18.75. The company has a current ratio of 5.19, a quick ratio of 5.19 and a debt-to-equity ratio of 0.92. The firm has a market capitalization of $5.05 billion, a PE ratio of 28.13, a price-to-earnings-growth ratio of 1.36 and a beta of 0.67.

Sabra Healthcare REIT Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, February 27th. Stockholders of record on Friday, February 13th will be paid a $0.30 dividend. This represents a $1.20 annualized dividend and a dividend yield of 5.9%. The ex-dividend date of this dividend is Friday, February 13th. Sabra Healthcare REIT’s dividend payout ratio (DPR) is 166.67%.

Hedge Funds Weigh In On Sabra Healthcare REIT

Hedge funds and other institutional investors have recently bought and sold shares of the business. Danske Bank A S bought a new stake in shares of Sabra Healthcare REIT during the 3rd quarter valued at $30,000. Larson Financial Group LLC grew its stake in shares of Sabra Healthcare REIT by 42.3% during the third quarter. Larson Financial Group LLC now owns 1,860 shares of the real estate investment trust’s stock worth $35,000 after purchasing an additional 553 shares during the period. EverSource Wealth Advisors LLC grew its stake in shares of Sabra Healthcare REIT by 150.7% during the second quarter. EverSource Wealth Advisors LLC now owns 2,555 shares of the real estate investment trust’s stock worth $47,000 after purchasing an additional 1,536 shares during the period. Quarry LP bought a new stake in Sabra Healthcare REIT in the third quarter valued at about $48,000. Finally, Virtu Financial LLC bought a new stake in Sabra Healthcare REIT in the third quarter valued at about $201,000. 99.40% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

SBRA has been the subject of a number of research reports. Jefferies Financial Group restated a “buy” rating and issued a $22.00 target price on shares of Sabra Healthcare REIT in a research note on Monday, December 15th. National Bank Financial set a $22.00 price objective on shares of Sabra Healthcare REIT in a research report on Friday, October 17th. UBS Group began coverage on shares of Sabra Healthcare REIT in a research note on Tuesday, November 18th. They issued a “neutral” rating and a $20.00 target price for the company. Weiss Ratings reiterated a “buy (b)” rating on shares of Sabra Healthcare REIT in a research report on Thursday, January 22nd. Finally, Truist Financial raised their price target on shares of Sabra Healthcare REIT from $20.00 to $21.00 and gave the company a “hold” rating in a report on Tuesday, January 20th. Four research analysts have rated the stock with a Buy rating and five have issued a Hold rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus price target of $21.11.

Sabra Healthcare REIT News Roundup

Here are the key news stories impacting Sabra Healthcare REIT this week:

• Positive Sentiment: Company issued FY2026 EPS guidance of $1.550–$1.590, well above Street consensus (~$1.06), signaling management expects materially stronger earnings next year — a primary driver of the stock rally. Read More.
• Positive Sentiment: Q4 results slightly beat EPS expectations (EPS $0.38 vs. $0.37) and showed 16% revenue growth year-over-year; FFO/AFFO were reported (FFO $0.36; AFFO $0.37 / normalized AFFO $0.38), supporting the view of resilient cash flow. Read More.
• Positive Sentiment: Company reiterated its dividend outlook in the 2026 outlook release, which reassures income-focused investors that management expects to sustain distributions alongside the upgraded earnings outlook. Read More.
• Neutral Sentiment: Operational detail: the company reported modest revenue miss versus a consensus line-item ($201.35M vs. $201.97M) and provided EBITDARM coverage metrics by business line — useful for credit/income investors but not immediately market-moving. Read More.
• Negative Sentiment: Analyst reaction was mixed: BMO reaffirmed a cautious/hold view, noting solid momentum in SHOP assets but a softer FFO outlook and uncertainty around an RCA loan that could pressure near-term cash flows — a risk that may cap multiple expansion. Read More.

Sabra Healthcare REIT Company Profile

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.